These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
205 related articles for article (PubMed ID: 8719476)
1. Cardiac allograft vasculopathy: the central pathogenetic role of ischemia-induced endothelial cell injury. Day JD; Rayburn BK; Gaudin PB; Baldwin WM; Lowenstein CJ; Kasper EK; Baughman KL; Baumgartner WA; Hutchins GM; Hruban RH J Heart Lung Transplant; 1995; 14(6 Pt 2):S142-9. PubMed ID: 8719476 [No Abstract] [Full Text] [Related]
2. Cardiac allograft vasculopathy: central role of endothelial injury leading to transplant "atheroma". Valantine HA Transplantation; 2003 Sep; 76(6):891-9. PubMed ID: 14508350 [TBL] [Abstract][Full Text] [Related]
5. The prognostic significance of intimal proliferation in cardiac allograft vasculopathy: a paradigm shift. Mehra MR; Ventura HO; Stapleton DD; Smart FW J Heart Lung Transplant; 1995; 14(6 Pt 2):S207-11. PubMed ID: 8719487 [No Abstract] [Full Text] [Related]
6. The pathogenesis of graft vascular disease: implications of vascular remodeling. Gibbons GH J Heart Lung Transplant; 1995; 14(6 Pt 2):S149-58. PubMed ID: 8719477 [No Abstract] [Full Text] [Related]
7. Vascular abnormalities and cardiomyocyte lipofuscin deposits in endomyocardial biopsy specimens of heart transplant recipients: are they related to the development of cardiac allograft vasculopathy? Zakliczynski M; Nozynski J; Konecka-Mrowka D; Krynicka-Mazurek A; Swierad M; Maruszewski M; Przybylski R; Zembala M J Thorac Cardiovasc Surg; 2009 Jul; 138(1):215-21, 221.e1-3. PubMed ID: 19577082 [TBL] [Abstract][Full Text] [Related]
8. Cytokine-mediated fibronectin production and transendothelial migration of lymphocytes in the mechanism of cardiac allograft vascular disease: efficacy of novel therapeutic approaches. Rabinovitch M; Molossi S; Clausell N J Heart Lung Transplant; 1995; 14(6 Pt 2):S116-23. PubMed ID: 8719473 [No Abstract] [Full Text] [Related]
9. Transplant arterial vasculopathy: evidence for a dual pattern of endothelial injury and the source of smooth muscle cells in lesions of intimal hyperplasia. Aziz S; McDonald TO; Gohra H J Heart Lung Transplant; 1995; 14(6 Pt 2):S123-36. PubMed ID: 8719474 [TBL] [Abstract][Full Text] [Related]
10. The role of histoincompatibility in cardiac allograft vasculopathy. Costanzo MR J Heart Lung Transplant; 1995; 14(6 Pt 2):S180-4. PubMed ID: 8719482 [No Abstract] [Full Text] [Related]
11. Cardiac allograft vasculopathy: pathology, prevention and treatment. Kass M; Haddad H Curr Opin Cardiol; 2006 Mar; 21(2):132-7. PubMed ID: 16470150 [TBL] [Abstract][Full Text] [Related]
15. The prognostic impact of immunosuppression and cellular rejection on cardiac allograft vasculopathy: time for a reappraisal. Mehra MR; Ventura HO; Chambers RB; Ramireddy K; Smart FW; Stapleton DD J Heart Lung Transplant; 1997 Jul; 16(7):743-51. PubMed ID: 9257256 [TBL] [Abstract][Full Text] [Related]
16. Ultrastructural evidence of myocardial alterations in the course of heterotopic heart transplantation. Ibba Manneschi L; Formigli L; Tani A; Perna AM; Zecchi Orlandini S J Submicrosc Cytol Pathol; 1996 Jul; 28(3):401-8. PubMed ID: 8765582 [TBL] [Abstract][Full Text] [Related]
17. [Pathological findings of transplanted heart]. Imakita M; Ueda H; Yutani C Tanpakushitsu Kakusan Koso; 1990 Jul; 35(10):1954-60. PubMed ID: 2236607 [No Abstract] [Full Text] [Related]
18. Does FK 506 accelerate the development of coronary artery disease in the transplanted heart as well as the native heart? Shibata T; Ogawa N; Koyama I; Ksaneko N; Hokazono K; Omoto R Transplant Proc; 1993 Feb; 25(1 Pt 2):1145-8. PubMed ID: 7680147 [No Abstract] [Full Text] [Related]